Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

The latest bulletin contains information on the following:

• MHRA Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)
• MHRA: Montelukast: reminder of the risk of neuropsychiatric reactions
• Revised SPC: Semaglutide-containing products (Wegovy, Ozempic, Rybelsus)
• Direct healthcare professional communication - Tresiba® FlexTouch® 100 units/mL solution for injection: update on supply shortage in the UK
• Change to Metoject® PEN device
• DHSC & NHSE: Influenza season 2023/24: ending the prescribing and supply of antiviral medicines in primary care
• Extension to serious shortage protocol (SSP059) for isosorbide mononitrate (Monomil® XL) 60mg modified-release tablets
• FSRH Statement: Extended use of all 52mg Levonorgestrel (LNG) IUDs for up to eight years for contraception (May 2024)

Download the bulletin here for more information and links:

• https://cpsc.org.uk/download_file/view/4620/3140